Compressed Gas Industry Expects Sufficient Dry Ice Supply for COVID-19 Vaccines in U.S. & Canada
Some of the COVID-19 vaccines currently under development require storage and transportation at extremely low temperatures. Dry ice (solid carbon dioxide) is needed to reach and maintain those temperatures.
The majority of carbon dioxide (CO2) and dry ice in the U.S. and Canada is produced by member companies of the Compressed Gas Association (CGA).
According to CGA members, the current production capacity for carbon dioxide and dry ice is expected to be sufficient to meet anticipated demand from vaccine manufacturers. There is also potential capacity to increase production and distribution of dry ice for COVID-19 vaccines, if needed.
To read the full CGA statement and for more information on this topic, visit the CGA website.